# Evaluation the Treatment of Tamoxifen of Low/Intermediate Risk Bladder Tumors

> **NCT02197897** · PHASE2 · COMPLETED · sponsor: **Baylor College of Medicine** · enrollment: 15 (actual)

## Conditions studied

- Bladder Cancer

## Interventions

- **DRUG:** Tamoxifen Citrate

## Key facts

- **NCT ID:** NCT02197897
- **Lead sponsor:** Baylor College of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-04-01
- **Primary completion:** 2017-09-12
- **Final completion:** 2019-06-28
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2021-01-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02197897

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02197897, "Evaluation the Treatment of Tamoxifen of Low/Intermediate Risk Bladder Tumors". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02197897. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*